Valence8 US »

Iovance Biotherapeutics shares owned by Valence8 US

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Valence8 US from 13F filings

Historical chart of Valence8 US investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Valence8 US consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Valence8 US

Quarter filed Position value Share count Share price at filing
2024-09-30 $123k 13k 9.39

More positions owned by Valence8 US

Ishares Tr Msci Usa Qlt Fct (QUAL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Msci Intl Qualty (IQLT)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds Value Etf (VTV)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Ishares Tr Msci Uk Etf New (EWU)
Ishares Msci Jpn Etf New (EWJ)
Astrazeneca Sponsored Adr Call Option (AZN)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Amgen Put Option (AMGN)
Soleno Therapeutics (SLNO)
Insmed Com Par $.01 Call Option (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Bristol Myers Squibb (BMY)

View all positions for Valence8 US

Top funds holding Iovance Biotherapeutics

Vanguard Group
Perceptive Advisors
MHR Fund Management
BlackRock
State Street Corporation
Soleus Capital Management
Hood River Capital Management
T. Rowe Price Investment Management
Geode Capital Management
Balyasny Asset Management
Artisan Partners Limited Partnership
Long Focus Capital Management
Goldman Sachs Group
venBio Select Advisor
Principal Financial Group

View all funds holding Iovance Biotherapeutics